Kaijie He

633 total citations
14 papers, 415 citations indexed

About

Kaijie He is a scholar working on Molecular Biology, Oncology and Physiology. According to data from OpenAlex, Kaijie He has authored 14 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Physiology. Recurrent topics in Kaijie He's work include Cancer Cells and Metastasis (3 papers), Cancer Research and Treatments (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Kaijie He is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Cancer Research and Treatments (2 papers) and Parkinson's Disease Mechanisms and Treatments (2 papers). Kaijie He collaborates with scholars based in China and United States. Kaijie He's co-authors include Amir Goldkorn, Tong Xu, Jinbao Zhang, Fen Wang, Chun‐Feng Liu, Yucheng Xu, Xiaobo Wang, Michaël Kahn, Alexander Ring and Zhixin Li and has published in prestigious journals such as Cancer Research, International Journal of Cancer and The Journals of Gerontology Series A.

In The Last Decade

Kaijie He

13 papers receiving 413 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kaijie He China	10	151	113	91	55	46	14	415
Yumi Ito Japan	14	250 1.7×	48 0.4×	63 0.7×	120 2.2×	26 0.6×	30	623
Jingying Chen China	12	241 1.6×	83 0.7×	57 0.6×	84 1.5×	17 0.4×	44	521
Egor Zindy United Kingdom	14	202 1.3×	52 0.5×	59 0.6×	110 2.0×	53 1.2×	30	464
Anyi Liu China	10	215 1.4×	92 0.8×	66 0.7×	29 0.5×	14 0.3×	13	455
Seema Aggarwal India	7	356 2.4×	66 0.6×	48 0.5×	35 0.6×	51 1.1×	19	579
Hongwei Yang China	12	264 1.7×	49 0.4×	43 0.5×	71 1.3×	45 1.0×	22	462
Ilida Suleymanova Finland	10	56 0.4×	69 0.6×	16 0.2×	22 0.4×	39 0.8×	17	272
Anqi Chen China	12	194 1.3×	61 0.5×	78 0.9×	8 0.1×	18 0.4×	31	539
Kevin C. Flanagan United States	10	331 2.2×	181 1.6×	259 2.8×	33 0.6×	310 6.7×	21	825
Chengyun Zheng China	11	144 1.0×	30 0.3×	28 0.3×	9 0.2×	68 1.5×	17	471

Countries citing papers authored by Kaijie He

Since Specialization

Citations

This map shows the geographic impact of Kaijie He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaijie He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaijie He more than expected).

Fields of papers citing papers by Kaijie He

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaijie He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaijie He. The network helps show where Kaijie He may publish in the future.

Co-authorship network of co-authors of Kaijie He

This figure shows the co-authorship network connecting the top 25 collaborators of Kaijie He. A scholar is included among the top collaborators of Kaijie He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaijie He. Kaijie He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Zhou, Shuaixiang, Yao Xiong, Jian Guan, et al.. (2024). Abstract LB057: Pre-clinical characterization of IBI343, a site-specifically conjugated anti-Claundin18.2 ADC, for treating solid tumors. Cancer Research. 84(7_Supplement). LB057–LB057.

Guan, Jian, Xiao Zhang, Weiwei Wu, et al.. (2024). Abstract LB055: IBI3001: A potentially first-in-class site-specifically conjugated B7-H3/EGFR bispecific ADC for multiple solid tumors. Cancer Research. 84(7_Supplement). LB055–LB055. 1 indexed citations

He, Kaijie, Canlong Zhang, Sheng Xie, Zhixin Li, & Zhijin Wang. (2023). Target-Aware Tracking with Long-Term Context Attention. Proceedings of the AAAI Conference on Artificial Intelligence. 37(1). 773–780. 44 indexed citations

He, Kaijie, Jinbao Zhang, Junyi Liu, et al.. (2023). LRRK2 G2019S promotes astrocytic inflammation induced by oligomeric α-synuclein through NF-κB pathway. iScience. 26(11). 108130–108130. 10 indexed citations

Wang, Xiaobo, Jinbao Zhang, Kaijie He, Fen Wang, & Chun‐Feng Liu. (2021). Advances of Zebrafish in Neurodegenerative Disease: From Models to Drug Discovery. Frontiers in Pharmacology. 12. 713963–713963. 73 indexed citations

Zhang, Yuting, Kaijie He, Jinbao Zhang, et al.. (2021). Advances in intranasal application of stem cells in the treatment of central nervous system diseases. Stem Cell Research & Therapy. 12(1). 210–210. 35 indexed citations

Ren, Chao, Fen Wang, Kaijie He, et al.. (2021). Early-Life Stress Induces Prodromal Features of Parkinsonism in Ageing Rats. The Journals of Gerontology Series A. 77(4). 705–716. 6 indexed citations

Wang, Yan, Haiqing Ni, Shuaixiang Zhou, et al.. (2020). Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicity. Cancer Immunology Immunotherapy. 70(2). 365–376. 87 indexed citations

He, Kaijie, Yuting Zhang, Shizhuang Wei, et al.. (2020). Impact of Maternal Separation on Dopamine System and its Association with Parkinson's Disease. NeuroMolecular Medicine. 22(3). 335–340. 5 indexed citations

10.

He, Kaijie, Jiahua Jiang, Xin Ye, et al.. (2019). Discovery of A Novel EGFR-Targeting Antibody–Drug Conjugate, SHR-A1307, for the Treatment of Solid Tumors Resistant or Refractory to Anti-EGFR Therapies. Molecular Cancer Therapeutics. 18(6). 1104–1114. 12 indexed citations

11.

He, Kaijie, Tong Xu, Yucheng Xu, et al.. (2013). Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem‐like phenotype through modulation of the PI3K/Akt/β‐catenin/CBP pathway. International Journal of Cancer. 134(1). 43–54. 57 indexed citations

12.

He, Kaijie, Tong Xu, & Amir Goldkorn. (2011). Cancer Cells Cyclically Lose and Regain Drug-Resistant Highly Tumorigenic Features Characteristic of a Cancer Stem-like Phenotype. Molecular Cancer Therapeutics. 10(6). 938–948. 44 indexed citations

13.

Xu, Tong, Kaijie He, Lina Wang, & Amir Goldkorn. (2011). Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference. The Prostate. 71(13). 1390–1400. 17 indexed citations

14.

Xu, Yucheng, Kaijie He, & Amir Goldkorn. (2011). Telomerase targeted therapy in cancer and cancer stem cells.. PubMed. 9(6). 442–55. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact